Skip to main content
Sinocare Inc. logo

Sinocare Inc. — Investor Relations & Filings

Ticker · 300298 ISIN · CNE100001CJ0 LEI · 3003008DEKI00A51LU77 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,250 across all filing types
Latest filing 2020-04-14 Remuneration Information
Country CN China
Listing Shenzhen Stock Exchange 300298

About Sinocare Inc.

https://www.sinocare.com

Sinocare Inc. specializes in the research, development, and manufacturing of biosensor technology and rapid testing products for chronic disease management. The company is primarily recognized for its blood glucose monitoring systems, including meters and test strips, which serve a global patient base. Its product portfolio extends to point-of-care testing (POCT) solutions for HbA1c, uric acid, blood lipids, and other metabolic indicators. Through the integration of advanced sensing technologies and digital health platforms, Sinocare provides comprehensive diagnostic tools for diabetes and related metabolic disorders. The company focuses on delivering affordable and accurate monitoring solutions to improve the quality of life for individuals with chronic conditions worldwide.

Recent filings

Filing Released Lang Actions
2020年度董事、监事及高级管理人员津贴和薪酬方案
Remuneration Information Classification · 95% confidence The document is titled as the 2020 remuneration and allowance plan for directors, supervisors, and senior management of the company. It details the salary standards, applicable personnel, and payment terms for the company's board members and executives. There is no financial data, audit information, or report of financial results. Instead, it focuses on compensation policies for top executives and board members. This matches the definition of Remuneration Information filings, which report compensation details for executives and directors.
2020-04-14 Chinese
2019年度独立董事述职报告（夏劲松）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director's Report for the year 2019" from SanNuo Biological Sensor Co., Ltd. It details the independent director's attendance at board meetings, opinions on company matters, committee work, and efforts to protect investor rights. The content focuses on governance, oversight, and compliance with laws and regulations, rather than financial results or audit opinions. The document length is 2871 characters, which is relatively short and does not contain financial statements or detailed financial data. It is a formal report by an independent director about their duties and activities during the year, which aligns with governance and board/management information. It is not an annual report, audit report, or earnings release. It is not a simple announcement or certification but a substantive report on board activities and governance. Therefore, the best fitting category is Board/Management Information (MANG).
2020-04-14 Chinese
2019年年度报告摘要
Annual Report Classification · 100% confidence The document is titled "三诺生物传感股份有限公司 2019 年年度报告摘要" which translates to "Sinocare Inc. 2019 Annual Report Summary." It contains detailed financial data for the year 2019, including revenue, net profit, earnings per share, and other financial indicators. It also includes comprehensive business descriptions, accounting policy changes, and operational analysis. The document is about 15,000 characters long, which is substantial and contains actual financial statements and analysis rather than just an announcement or summary notice. The presence of audited financial data and detailed management discussion confirms it is an Annual Report. Therefore, the document fits the definition of an Annual Report (10-K).
2020-04-14 Chinese
2020年第一次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2020 first extraordinary general meeting (临时股东大会) of 三诺生物传感股份有限公司. It includes detailed voting results for multiple proposals related to the issuance of convertible bonds, use of funds, guarantees, and other corporate actions. The document contains no financial statements or management discussion of financial results, but rather the official voting outcomes and meeting procedural details. This matches the definition of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is substantial and contains full voting results, not just a brief announcement or a notice of report publication. Therefore, the correct classification is DVA with high confidence.
2020-04-09 Chinese
2020年第一次临时股东大会的法律意见书
Regulatory Filings
2020-04-09 Chinese
2020年第一季度业绩预告
Earnings Release Classification · 95% confidence The document is titled as a "2020年第一季度业绩预告" which translates to "2020 First Quarter Earnings Forecast." It provides estimated financial results for the period January 1, 2020 to March 31, 2020, including expected net profit increases and explanations for performance changes. The document explicitly states that the financial data is preliminary and unaudited, and that detailed financial data will be disclosed in the company's "2020年第一季度报告" (2020 First Quarter Report). This indicates the document is an earnings forecast or earnings release rather than a full interim report containing actual audited financial statements. The document length is short (1136 characters), and it is a forward-looking earnings announcement with key highlights only, matching the definition of an Earnings Release (ER).
2020-04-07 Chinese

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.